Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-11-01
著者
-
McKenzie Andrew
MRC Lab
-
GAO Wei
Centocor Research and Development, a division of Johnson & Johnson Pharmaceutical Research & Development
-
SPRENKLE Justin
Centocor Research and Development, a division of Johnson & Johnson Pharmaceutical Research & Development
-
BARLOW Jillian
MRC Laboratory of Molecular Biology
-
WONG See
MedImmune
-
CAMELO Ana
MRC Laboratory of Molecular Biology
-
DRYNAN Lesley
MRC Laboratory of Molecular Biology
-
NEILL Daniel
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool
-
BALLANTYNE Sarah
MRC Laboratory of Molecular Biology
-
PANNELL Richard
MRC Laboratory of Molecular Biology
-
WRIGLEY Keely
Centocor Research and Development, a division of Johnson & Johnson Pharmaceutical Research & Development
関連論文
- 386 ダニ抗原誘発マウス気道炎症におけるTh2サイトカインの意義(2)(動物モデル7,一般演題(口演),第56回日本アレルギー学会秋季学術大会)
- Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13